Vascular Endothelial Growth Factor Inhibitor drugs compared
Compare all 3 Vascular Endothelial Growth Factor Inhibitor drugs side by side, used for conditions such as carcinoma, non-small-cell lung, uterine cervical neoplasms, fallopian tube neoplasms. They share one FDA-defined mechanism but differ in approved uses, prescription status, brand-vs-generic options, price, and FDA recall-safety record — which our independent rating scores. The highest-rated is avastin.
Top-rated vascular endothelial growth factor inhibitor: 1. Avastin · 2. Lucentis · 3. Susvimo
| Drug | Generic | Form | Status | Used for | Safety ratingFDA recall-based | Pharmacy pays |
|---|---|---|---|---|---|---|
| Avastin | Bevacizumab | Injectable | Prescription | Carcinoma, Non-Small-Cell Lung, Uterine Cervical Neoplasms | 70/100 | — |
| Lucentis | Ranibizumab | Injectable | Prescription | Diabetic Retinopathy, Macular Edema | 70/100 | — |
| Susvimo | Ranibizumab | Injectable | Prescription | Diabetic Retinopathy, Macular Edema | 70/100 | — |
The safety rating column is unique to pharmaranks — an independent 0–100 score from FDA regulatory recall data. Higher is safer. Not medical advice.
Full ranking · 3 drugs
Frequently asked questions
What is the Vascular Endothelial Growth Factor Inhibitor drug class?
Vascular Endothelial Growth Factor Inhibitor is an FDA Established Pharmacologic Class (EPC) — a group of drugs that share a mechanism of action. pharmaranks lists 3 Vascular Endothelial Growth Factor Inhibitor products, each independently rated.
Are all Vascular Endothelial Growth Factor Inhibitor drugs the same?
No. Vascular Endothelial Growth Factor Inhibitor drugs share the same core mechanism — that is why they sit in one FDA class — but they differ in their approved uses, available forms, whether they are prescription or over-the-counter, brand-vs-generic options and price, and their FDA recall-safety record.
What conditions do Vascular Endothelial Growth Factor Inhibitor drugs treat?
Per NIH RxClass drug-classification data, Vascular Endothelial Growth Factor Inhibitor drugs are used for conditions including carcinoma, non-small-cell lung, uterine cervical neoplasms, fallopian tube neoplasms, glioblastoma, kidney neoplasms, ovarian neoplasms.
Which Vascular Endothelial Growth Factor Inhibitor drug is best-rated?
By our independent rating, avastin currently ranks highest among Vascular Endothelial Growth Factor Inhibitor drugs. Ratings are based on FDA regulatory (recall-safety) data — always consult a professional.
Sources: the Vascular Endothelial Growth Factor Inhibitor class definition and its member drugs come from the U.S. NLM RxClass (Established Pharmacologic Class); how the class works is summarized from Aflibercept - StatPearls - NCBI Bookshelf. Ratings are pharmaranks’ independent FDA recall-safety analysis.